Brain Swelling on the Rise in Unvaccinated Kids With Influenza
They identified 41 children around the age of five who developed the complication know as acute necrotizing encephalopathy over the past two flu seasons. Eleven died within days due to the building pressure in their brains, according to the report published Wednesday in the Journal of the American Medical Association.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
7 minutes ago
- Yahoo
Recovery.com Acquires Recovery Brands Care Navigation Platform from American Addiction Centers in Eight-Figure Deal to Expand Access to Care
Strategic acquisition of premier sites doubles reach, solidifying leading market position and accelerating access to trusted treatment options for millions MADISON, Wis., Aug. 07, 2025 (GLOBE NEWSWIRE) -- and American Addiction Centers (AAC) today announced the sale and transition of several leading addiction treatment care navigation websites from AAC subsidiary Recovery Brands to The sites include and The transition reflects a commitment from both parties to help individuals and families find addiction treatment options that meet their individual needs, and a recognition that digital platforms are often the first step in that journey. For the acquisition represents an opportunity to expand its impact and further strengthen the tools and resources available to individuals navigating the treatment landscape. 'We've spent many years and invested millions of dollars building the best place on the internet to find mental health and addiction treatment and by bringing these websites under our ownership our impact and reach essentially doubled overnight,' said Ben Camp, CEO of 'We've long believed we were a perfect home for these websites, and I'm so glad that AAC's leadership decided the time was right to sell. This is a major win for patients and for the industry.' 'This transaction reflects AAC's continued commitment to expanding access to lifesaving care through mission-aligned partnerships,' said Dr. David Hans, Co-CEO of American Addiction Centers. 'Our vision as a company is to foster a world free from the stigma of addiction, where quality treatment and support are accessible for all.' 'Recovery Brands has been a trusted digital front door to treatment for millions, and this strategic sale enables to scale that impact even further—while allowing AAC to sharpen its focus on delivering high-quality, patient-centered care across our facilities nationwide,' said Ellen-Jo Boschert, Co-CEO of American Addiction Centers. The sale marks a meaningful step forward for both organizations as access to treatment remains critical. About in 2017, is the leading global platform for finding trusted mental health and addiction treatment. Each month, millions of people engage with us across our websites and social media platforms to search 20,000+ providers, compare treatment center details and reviews, read helpful recovery resources, interact with community content, and connect directly with the right treatment for them. We list all treatment options on our care navigation websites at no cost, while providing an ethical, best-in-class advertising platform for LegitScript-certified addiction treatment and mental health providers. Learn more at About American Addiction Centers At American Addiction Centers (AAC), we believe in the power of recovery. As a national leader in substance use disorder treatment, we provide compassionate, evidence-based inpatient and outpatient care for individuals struggling with addiction and mental health disorders. Our mission is to restore hope and empower individuals and families, offering a foundation for lasting recovery that transforms lives. We envision a world free from the stigma of addiction, where high-quality care is accessible to all. Learn more at Media Contacts: Jeremy Tunis, Senior Advisor, Public Affairs and Communications American Addiction Centers Joy Sutton, VP of Brand and Communications jsutton@ in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Yahoo
7 minutes ago
- Yahoo
RFK Jr.'s vow to overhaul vaccine injury program echoes grievances of anti-vaccine movement
WASHINGTON (AP) — Health Secretary Robert F. Kennedy Jr. is vowing to 'fix' the federal program for compensating Americans injured by vaccines, opening the door to sweeping changes for a system long targeted by anti-vaccine activists. Health experts and lawyers say updates are needed to help clear a backlog of cases in the Vaccine Injury Compensation Program, created by Congress in 1986 as a no-fault payment system for presumed vaccine injuries. But they also worry Kennedy's changes will reflect his history as a leader in the anti-vaccine movement, which has alternately called for abolishing the program or expanding it to cover unproven injuries and illnesses that aren't connected to vaccines. Kennedy and other critics believe the program is 'too miserly in what it considers to be a vaccine injury,' said Jason Schwartz, a public health expert at Yale University. 'That's created great concern that he could expand what's included.' Anti-vaccine groups have long suggested a link between vaccines and autism, despite scientific consensus that childhood vaccines don't cause the condition. Adding autism to the list of injuries covered by the plan 'would dramatically increase the number of compensable cases, potentially bankrupting it," Schwartz said. Program is credited with saving the U.S. vaccine industry Signed into law under President Ronald Reagan, the compensation program is designed to provide quick, efficient compensation to Americans who report known injuries associated with vaccines, such as rare allergic reactions. At the time of its creation, a number of vaccine-makers were exiting the business due to risks of class action lawsuits. In a recent social media post, Kennedy called the program 'broken' and accused federal lawyers and adjudicators who run it of 'inefficiency, favoritism and outright corruption.' Kennedy didn't specify the changes he's seeking. But some of the people he's enlisted to help have a history of bringing vaccine injury cases. In June, the Department of Health and Human Services awarded a $150,000 contract to an Arizona law firm for 'expertise' in the program. The firm's Andrew Downing, an attorney specializing in vaccine injury cases, was listed in the HHS staff directory for a time. 'We just brought a guy in this week who is going to be revolutionizing the Vaccine Injury Compensation Program,' Kennedy told Tucker Carlson shortly after the award. Revamping the program would be the latest in a string of decisions that have upended U.S. vaccine policy, including this week's cancellation of research funding for vaccines using mRNA technology. Downing and Kennedy have had roles in HPV vaccine lawsuits Downing has had a leading role in lawsuits against Merck alleging injuries from its HPV vaccine, Gardasil, including a rare movement disorder. In a podcast last year for people with the condition, Downing lamented that the injury compensation program 'has taken a hard line' against such cases, leading lawyers to file injury lawsuits in civil court. Approximately 70% of the Gardasil cases against Merck started as claims filed by Downing in the federal injury program, according to court records. A judge dismissed more than 120 of those cases, citing 'a paucity of evidence" that Gardasil caused patients' problems. A spokesman for Kennedy declined to comment on Downing's hiring. Kennedy himself has been involved in the Gardasil litigation, as both an attorney and consultant. Before joining the government, Kennedy received payments for referring potential Gardasil clients to Wisner Baum, one of the law firms suing Merck. Following questions about the agreement during his confirmation hearings, Kennedy agreed to give up his stake in the deal and transfer any future fees to 'a nondependent, adult son," according to his financial disclosures. One of Kennedy's sons is an attorney at Wisner Baum. Experts see need for reform Experts who study vaccine compensation say real changes are needed to modernize the 40-year-old program. The cap on compensation remains $250,000 for injury or death, the same as in 1986. Similarly, the program still has eight adjudicators, known as special masters, to review all cases before the government. On average, the process takes two to three years. The fund has paid out $5.4 billion, compensating about 40% of all people who filed claims. The U.S. has an 'ethical obligation' to promptly pay those harmed by government-recommended vaccines, says Dorit Reiss, a professor at the University of California Hastings College of the Law. 'Plus, I think it increases trust in the vaccination program if you have quick, generous compensation,' Reiss said. One possible change: Adding injuries As health secretary, Kennedy has broad powers to reshape the program. One approach could be adding new diseases and illnesses to the government table of payable injuries. In the early 2000s, the program ruled against more than 5,000 claims from families who said vaccines led to their children's autism, citing hundreds of scientific studies discrediting the link. Critics of Kennedy say he could claim that he has new evidence of harm — perhaps from a large autism study he's commissioned — and add the condition to the program. In response, the federal government might have to increase taxes on vaccines to replenish the compensation fund, which would make the shots more expensive and less accessible. 'Then you will start to watch the vaccine program infrastructure in this country disintegrate until someone steps in,' Dr. Paul Offit, a vaccine researcher at Children's Hospital of Philadelphia who has clashed with Kennedy for years. A recent Senate hearing titled 'Voice of the Vaccine Injured' appeared to make the case for expanding the program. Witnesses included two representatives from Children's Health Defense, the nonprofit group that Kennedy previously chaired and has repeatedly sued the government over vaccines. The group's chief science officer, Brian Hooker, told lawmakers he tried unsuccessfully for 16 years trying to get compensation for his son's autism, which he attributes to the measles-mumps-rubella vaccine. Another possible change: Removing vaccines Another approach would involve removing certain vaccines from the program, making it easier to bring lawsuits against vaccine-makers. Under current law, people claiming injuries from vaccines covered by the program must first pursue a compensation claim before they can sue. In cases where the science doesn't support a connection to vaccines, lawyers might be more successful before a jury. 'Jury trials take advantage of the fact that most jurors don't know anything about science or medicine,' Offit said. 'They are not going to be as easily moved by the data.' Still, attorneys who bring cases before the compensation program say the process has become more burdensome and adversarial over the years. Even small changes could improve things. For instance, the statute of limitations for claims could be extended beyond the current three years, which lawyers say cuts off many potential clients. 'I'm hoping there will be changes put in place that make the program easier for petitioners to navigate' said Leah Durant, a vaccine injury attorney. ___ The Associated Press Health and Science Department receives support from the Howard Hughes Medical Institute's Department of Science Education and the Robert Wood Johnson Foundation. The AP is solely responsible for all content. Solve the daily Crossword
Medscape
9 minutes ago
- Medscape
Does Obesity Raise AF Risk Directly or Via Comorbidities?
TOPLINE: Individuals with overweight or obesity have a higher risk for atrial fibrillation (AF) than those with normal weight. Nearly one fourth of the increased risk with obesity is mediated by comorbid conditions, whereas the remaining risk is directly mediated by obesity. METHODOLOGY: Obesity is associated with an increased risk for AF, yet it remains unclear whether this risk stems directly from excess adiposity or is mediated by comorbid conditions. Researchers conducted a retrospective cohort study of patients aged ≥ 40 years with a documented BMI across German general practices between 2005 and 2023. Participants were categorized as underweight (BMI < 18.5), normal weight (18.5-24.9), overweight (25.0-29.9), or obesity (≥ 30). The primary outcome was incident AF within 10 years of the index date. A causal mediation analysis estimated the proportion of AF risk mediated by comorbidities, including type 2 diabetes, hypertension, dyslipidemia, ischemic heart disease, and heart failure. TAKEAWAY: The study included 1 22,464 participants with normal weight (mean age, 58.9 years; 61.6% women), 150,783 with overweight (mean age, 60.7 years; 44.5% women), and 112,674 with obesity (mean age, 60.1 years; 53% women). Over 10 years, AF occurred in 7.2% of participants with normal weight, 10.1% with overweight, and 13.2% with obesity. Compared to those with normal weight, the risk for AF was 43% higher among individuals with obesity (P <.001) and 12% higher among those with overweight (P < .001), with greater risks in men. Mediation analysis revealed that 27% of obesity-related AF risk was mediated by comorbidities, whereas 79% was attributed to direct effects of obesity. IN PRACTICE: "Effective management of hypertension, diabetes and dyslipidaemia could help to achieve a meaningful reduction in the proportion of AF cases attributable to obesity. At the same time, the persistent direct effect of BMI on AF, despite adjustment for comorbidities, indicates that weight reduction must remain a central focus of preventive strategies," the authors wrote. SOURCE: This study was led by Jamschid Sedighi, MD, Justus-Liebig-University in Giessen, Germany. It was published online in Diabetes, Obesity and Metabolism. LIMITATIONS: BMI was measured only at baseline; thus, associations reflect initial BMI rather than changes over time. Confounding factors may have remained. Reliance on diagnostic codes may have underestimated the cases of paroxysmal or asymptomatic AF. DISCLOSURES: No specific study funding was reported. Two authors disclosed receiving speaker/consulting honoraria from AstraZeneca and Pfizer, and one also received honoraria from additional sources including Novartis, Berlin-Chemie, and Lilly. This article was created using several editorial tools, including AI, as part of the process. Human editors reviewed this content before publication.
